Director/PDMR Shareholding

Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4

On 8 May 2015, Marc Dunoyer, a Director of the Company, notified us that, on 7 May 2015, he purchased 10,000 AstraZeneca PLC Ordinary Shares of $0.25 each at a price of 4397 pence per share.

A C N Kemp
Company Secretary
8 May 2015

About Us

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit:


Documents & Links